Make faster, better drug development decisions
With increasing competition and complexity, the chance of successfully getting your oncology drug to market will fall even lower than the current 4%. It is more crucial than ever to benchmark your drug against comparable technologies, as well as understand how you are positioned against the disease indication competition.
Beacon Oncology is designed for drug developers who need comprehensive and granular scientific insights for oncology drugs and clinical trials to make the informed decisions.
Concerned you are missing insights critical to your Oncology R&D strategy?
Beacon Oncology provides you with the most comprehensive and accurate scientific data to provide you with the confidence that your drug candidate is differentiated and has commercial success potential.
23k+ Drugs and 47k+Trials
The most comprehensive and exhaustive coverage of the Oncology drug pipeline and clinical trial landscape.
50+ Filters
Provide you with the ability to surface insights relevant to your R&D programs and cut out the noise.
Curated Scientific Insights
What we encompass
ALL ONCOLOGY TRIALS
Every oncology clinical trial since 2011, including chemotherapies
23k+ DRUGS & THERAPIES
Every drug or therapy deployed in those trials both active and inactive
UNRIVALLED PRECLINICAL AND CLINICAL DETAIL
Key data points summarised from all clinical and preclinical sources, from the models, assays and dosing of preclinical pk studies to ORR, PFS, DLTs and Adverse events extracted from Clinical Trials, all with links to the posters, presentations and abstracts
Our commitment to high quality data
EXCEPTIONAL TIMELINESS
Updates published within 48hrs of public disclosure
HUMAN INTELLIGENCE
All data manually by sector specialist scientists
GRANULAR ONTOLOGIES
Structured data, easily searched through 50+ filters
What our customers say
Beacon is a great database that people should pay attention to. It's much better than many generic databases that try to capture all data about everything.
Director
Top Biotech Company
Any questions? Contact us
To learn more about how we can tailor Beacon Oncology to help you, get in touch with our sales team
About Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies and the most accurate and comprehensive life sciences data provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Other Beacon Solutions
Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more
Covering all genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications
Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more
Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.
Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets
Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.
Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.
From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.
Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.
Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.
Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.
Beacon TPD provides the solution you need to master the targeted protein degradation field.
